Clinical Trial Update: Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing olanzapine alone to low-dose olanzapine plus trifluoperazine for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)
• trifluoperazine (trifluoperazine)

Snippet

Sponsor: Kaohsiung Kai-Suan Psychiatric Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED